Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Towa Pharmaceutical Co., Ltd. (4553.T)

Compare
2,530.00
-57.00
(-2.20%)
At close: April 4 at 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Itsuro Yoshida President & Representative Director -- -- 1951
Shiro Hatagami Executive Officer and GM of Accounting & Finance Division -- -- --
Mr. Norikazu Inoue Executive Officer & GM of Administration Division -- -- 1959
Shigeki Fujita Operating Officer & GM of Human Resource Development Center -- -- --
Yutaka Okuda Senior OO & Division Manager of R&D Division and Unit Manager of Innovative Tech Research Unit -- -- --
Mr. Masao Tanaka Director -- -- 1954
Tetsuro Tabata Senior Executive Officer & GM of Production Division -- -- --
Takeshi Sugiura Executive Officer -- -- --
Yasuyuki Oishi Executive Officer -- -- --

Towa Pharmaceutical Co., Ltd.

2-11, Shinbashi-cho
Kadoma
Osaka, 571-8580
Japan
81 6 6900 9100 https://www.towayakuhin.co.jp
Sector: 
Healthcare
Full Time Employees: 
4,588

Description

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.

Corporate Governance

Towa Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of April 1, 2025 is 6. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 2; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 6:00 AM UTC - May 16, 2025 at 6:00 AM UTC

Towa Pharmaceutical Co., Ltd. Earnings Date

Recent Events

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date